MEDIFAST Interest Expense vs Non Operating Income Net Other Analysis

MED Stock

USD 33.71 0.21 0.63%

MEDIFAST INC financial indicator trend analysis is infinitely more than just investigating MEDIFAST INC recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether MEDIFAST INC is a good investment. Please check the relationship between MEDIFAST INC Interest Expense and its Non Operating Income Net Other accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MEDIFAST INC. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.

For information on how to trade MEDIFAST Stock refer to our How to Trade MEDIFAST Stock guide.

Interest Expense vs Non Operating Income Net Other

Interest Expense vs Non Operating Income Net Other Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of MEDIFAST INC Interest Expense account and Non Operating Income Net Other. At this time, the significance of the direction appears to have significant contrarian relationship.

The correlation between MEDIFAST INC's Interest Expense and Non Operating Income Net Other is -0.39. Overlapping area represents the amount of variation of Interest Expense that can explain the historical movement of Non Operating Income Net Other in the same time period over historical financial statements of MEDIFAST INC, assuming nothing else is changed. The correlation between historical values of MEDIFAST INC's Interest Expense and Non Operating Income Net Other is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Interest Expense of MEDIFAST INC are associated (or correlated) with its Non Operating Income Net Other. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Non Operating Income Net Other has no effect on the direction of Interest Expense i.e., MEDIFAST INC's Interest Expense and Non Operating Income Net Other go up and down completely randomly.

Correlation Coefficient

-0.39

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Interest Expense

The cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit.

Non Operating Income Net Other

Most indicators from MEDIFAST INC's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into MEDIFAST INC current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MEDIFAST INC. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.

For information on how to trade MEDIFAST Stock refer to our How to Trade MEDIFAST Stock guide.At present, MEDIFAST INC's Discontinued Operations is projected to increase significantly based on the last few years of reporting. The current year's Enterprise Value is expected to grow to about 417.1 M, whereas Sales General And Administrative To Revenue is forecasted to decline to 0.48.

	2021	2022	2023	2024 (projected)
Gross Profit	1.1B	1.1B	775.9M	814.6M
Total Revenue	1.5B	1.6B	1.1B	1.1B

Gross Profit Total Revenue

MEDIFAST INC fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Common Stock	Accounts Payable	Other Assets
Total Assets		0.9	0.9	0.95	0.96	0.89	-0.63	0.91	0.81	0.9	0.25	0.79	0.31	0.19	0.2	0.79	0.8	0.66	0.13	0.96	0.88	0.99	0.86	0.19	0.71	0.85
Short Long Term Debt Total	0.9		0.91	0.91	0.82	0.79	-0.46	0.78	0.66	0.82	0.4	0.61	0.25	0.0	-0.03	0.74	0.82	0.64	0.03	0.91	0.83	0.89	0.86	0.0	0.74	0.79
Other Current Liab	0.9	0.91		0.97	0.78	0.73	-0.66	0.82	0.81	0.74	0.37	0.68	0.07	0.04	0.03	0.7	0.84	0.65	-0.13	0.96	0.71	0.92	0.84	0.04	0.74	0.75
Total Current Liabilities	0.95	0.91	0.97		0.84	0.82	-0.63	0.84	0.79	0.82	0.28	0.68	0.08	0.04	0.06	0.77	0.9	0.71	-0.01	1.0	0.79	0.96	0.85	0.04	0.76	0.77
Total Stockholder Equity	0.96	0.82	0.78	0.84		0.85	-0.65	0.92	0.8	0.87	0.22	0.87	0.49	0.3	0.3	0.7	0.63	0.53	0.22	0.84	0.86	0.95	0.77	0.3	0.62	0.86
Property Plant And Equipment Net	0.89	0.79	0.73	0.82	0.85		-0.27	0.74	0.49	0.99	0.09	0.53	0.37	0.33	0.3	0.95	0.74	0.74	0.26	0.86	0.97	0.81	0.84	0.32	0.53	0.77
Net Debt	-0.63	-0.46	-0.66	-0.63	-0.65	-0.27		-0.72	-0.96	-0.28	-0.3	-0.89	-0.03	-0.14	-0.19	-0.1	-0.36	-0.15	0.12	-0.57	-0.25	-0.73	-0.36	-0.14	-0.54	-0.53
Retained Earnings	0.91	0.78	0.82	0.84	0.92	0.74	-0.72		0.84	0.74	0.22	0.87	0.34	0.29	0.33	0.59	0.63	0.55	-0.13	0.83	0.72	0.93	0.69	0.29	0.63	0.71
Cash	0.81	0.66	0.81	0.79	0.8	0.49	-0.96	0.84		0.51	0.35	0.93	0.15	0.12	0.15	0.34	0.53	0.31	-0.06	0.75	0.48	0.87	0.59	0.12	0.6	0.7
Non Current Assets Total	0.9	0.82	0.74	0.82	0.87	0.99	-0.28	0.74	0.51		0.14	0.56	0.45	0.26	0.21	0.93	0.71	0.7	0.29	0.86	0.99	0.82	0.88	0.25	0.52	0.84
Non Currrent Assets Other	0.25	0.4	0.37	0.28	0.22	0.09	-0.3	0.22	0.35	0.14		0.26	0.09	-0.04	-0.22	0.08	0.22	-0.12	0.08	0.26	0.16	0.28	0.33	-0.04	0.25	0.29
Cash And Short Term Investments	0.79	0.61	0.68	0.68	0.87	0.53	-0.89	0.87	0.93	0.56	0.26		0.45	0.24	0.25	0.33	0.35	0.22	0.05	0.65	0.55	0.84	0.56	0.24	0.47	0.76
Net Receivables	0.31	0.25	0.07	0.08	0.49	0.37	-0.03	0.34	0.15	0.45	0.09	0.45		0.09	-0.03	0.26	-0.19	-0.12	0.34	0.1	0.51	0.24	0.43	0.09	-0.2	0.59
Common Stock Total Equity	0.19	0.0	0.04	0.04	0.3	0.33	-0.14	0.29	0.12	0.26	-0.04	0.24	0.09		0.94	0.25	0.02	0.26	0.06	0.07	0.18	0.16	-0.11	1.0	0.2	0.0
Common Stock Shares Outstanding	0.2	-0.03	0.03	0.06	0.3	0.3	-0.19	0.33	0.15	0.21	-0.22	0.25	-0.03	0.94		0.19	0.03	0.29	-0.04	0.08	0.13	0.18	-0.18	0.94	0.21	-0.06
Non Current Liabilities Total	0.79	0.74	0.7	0.77	0.7	0.95	-0.1	0.59	0.34	0.93	0.08	0.33	0.26	0.25	0.19		0.77	0.78	0.23	0.82	0.9	0.71	0.84	0.25	0.45	0.65
Inventory	0.8	0.82	0.84	0.9	0.63	0.74	-0.36	0.63	0.53	0.71	0.22	0.35	-0.19	0.02	0.03	0.77		0.8	0.0	0.91	0.68	0.8	0.71	0.02	0.81	0.5
Other Current Assets	0.66	0.64	0.65	0.71	0.53	0.74	-0.15	0.55	0.31	0.7	-0.12	0.22	-0.12	0.26	0.29	0.78	0.8		-0.05	0.74	0.65	0.62	0.56	0.26	0.63	0.38
Other Stockholder Equity	0.13	0.03	-0.13	-0.01	0.22	0.26	0.12	-0.13	-0.06	0.29	0.08	0.05	0.34	0.06	-0.04	0.23	0.0	-0.05		0.02	0.34	0.06	0.16	0.06	-0.02	0.32
Total Liab	0.96	0.91	0.96	1.0	0.84	0.86	-0.57	0.83	0.75	0.86	0.26	0.65	0.1	0.07	0.08	0.82	0.91	0.74	0.02		0.83	0.95	0.88	0.07	0.74	0.77
Property Plant And Equipment Gross	0.88	0.83	0.71	0.79	0.86	0.97	-0.25	0.72	0.48	0.99	0.16	0.55	0.51	0.18	0.13	0.9	0.68	0.65	0.34	0.83		0.8	0.89	0.18	0.49	0.86
Total Current Assets	0.99	0.89	0.92	0.96	0.95	0.81	-0.73	0.93	0.87	0.82	0.28	0.84	0.24	0.16	0.18	0.71	0.8	0.62	0.06	0.95	0.8		0.81	0.16	0.74	0.81
Short Term Debt	0.86	0.86	0.84	0.85	0.77	0.84	-0.36	0.69	0.59	0.88	0.33	0.56	0.43	-0.11	-0.18	0.84	0.71	0.56	0.16	0.88	0.89	0.81		-0.12	0.41	0.88
Common Stock	0.19	0.0	0.04	0.04	0.3	0.32	-0.14	0.29	0.12	0.25	-0.04	0.24	0.09	1.0	0.94	0.25	0.02	0.26	0.06	0.07	0.18	0.16	-0.12		0.2	0.0
Accounts Payable	0.71	0.74	0.74	0.76	0.62	0.53	-0.54	0.63	0.6	0.52	0.25	0.47	-0.2	0.2	0.21	0.45	0.81	0.63	-0.02	0.74	0.49	0.74	0.41	0.2		0.44
Other Assets	0.85	0.79	0.75	0.77	0.86	0.77	-0.53	0.71	0.7	0.84	0.29	0.76	0.59	0.0	-0.06	0.65	0.5	0.38	0.32	0.77	0.86	0.81	0.88	0.0	0.44

Click cells to compare fundamentals

MEDIFAST INC Account Relationship Matchups

MEDIFAST INC fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	194.7M	276.1M	398.3M	316.2M	309.9M	325.4M
Other Current Liab	49.3M	64.3M	84.4M	69.1M	46.6M	49.0M
Total Current Liabilities	79.4M	111.4M	169.8M	140.9M	92.3M	96.9M
Total Stockholder Equity	104.8M	157.2M	202.5M	155.0M	201.5M	211.6M
Property Plant And Equipment Net	38.8M	38.1M	80.6M	75.6M	67.1M	70.5M
Net Debt	(63.4M)	(152.6M)	(71.6M)	(61.6M)	(72.4M)	(68.8M)
Retained Earnings	168.8M	154.4M	190.3M	139.9M	174.6M	183.4M
Cash	77.0M	163.7M	104.2M	87.7M	94.4M	99.2M
Non Current Assets Total	40.5M	41.8M	91.5M	93.4M	85.9M	90.2M
Non Currrent Assets Other	353K	2.9M	6.5M	12.5M	14.7M	15.4M
Cash And Short Term Investments	92.7M	174.5M	109.5M	87.7M	150.0M	157.5M
Net Receivables	1.0M	1.4M	584K	1.0	8.7M	9.2M
Common Stock Shares Outstanding	12.1M	11.9M	11.8M	11.3M	10.9M	12.2M
Liabilities And Stockholders Equity	194.7M	276.1M	398.3M	316.2M	309.9M	325.4M
Non Current Liabilities Total	10.4M	7.5M	26.0M	20.3M	16.1M	16.9M
Inventory	48.8M	53.4M	180.0M	118.9M	54.6M	27.8M
Other Current Assets	11.3M	5.9M	17.3M	16.2M	10.7M	5.5M
Other Stockholder Equity	(64.0M)	2.8M	12.0M	15.2M	26.6M	27.9M
Total Liab	89.8M	118.8M	195.9M	161.2M	108.4M	113.8M
Property Plant And Equipment Gross	38.8M	38.1M	113.3M	115.6M	114.4M	120.1M
Total Current Assets	154.2M	234.3M	306.9M	222.8M	224.0M	235.2M
Short Term Debt	3.2M	3.7M	6.5M	5.8M	5.9M	6.2M
Accounts Payable	22.6M	35.8M	70.9M	58.7M	39.2M	21.4M
Accumulated Other Comprehensive Income	25K	41K	111K	24K	248K	260.4K
Other Assets	1.7M	14.1M	10.9M	17.8M	20.5M	21.5M
Short Term Investments	15.7M	10.8M	5.4M	(23K)	55.6M	58.4M
Property Plant Equipment	26.0M	27.6M	56.1M	57.2M	65.8M	69.1M
Net Tangible Assets	104.8M	157.2M	202.5M	155.0M	178.3M	125.0M
Retained Earnings Total Equity	168.8M	154.4M	190.3M	139.9M	160.8M	126.9M
Capital Surpluse	0.0	7.8M	12.0M	21.6M	19.4M	10.8M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether MEDIFAST INC is a strong investment it is important to analyze MEDIFAST INC's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact MEDIFAST INC's future performance. For an informed investment choice regarding MEDIFAST Stock, refer to the following important reports:

How To Invest In MEDIFAST

Details

Is MEDIFAST Stock a good investment?

Details

What is MEDIFAST INC's Net Worth?

Details

Largest Personal Care Products Companies

View

Largest Household & Personal Products Companies

View

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MEDIFAST INC. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.

For information on how to trade MEDIFAST Stock refer to our How to Trade MEDIFAST Stock guide.

Note that the MEDIFAST INC information on this page should be used as a complementary analysis to other MEDIFAST INC's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Complementary Tools for MEDIFAST Stock analysis

When running MEDIFAST INC's price analysis, check to measure MEDIFAST INC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MEDIFAST INC is operating at the current time. Most of MEDIFAST INC's value examination focuses on studying past and present price action to predict the probability of MEDIFAST INC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MEDIFAST INC's price. Additionally, you may evaluate how the addition of MEDIFAST INC to your portfolios can decrease your overall portfolio volatility.

	Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
	Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated
	CEOs Directory Screen CEOs from public companies around the world
	Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
	Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
	Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas

Is MEDIFAST INC's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MEDIFAST INC. If investors know MEDIFAST will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MEDIFAST INC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.77)

Dividend Share

4.95

Earnings Share

9.1

Revenue Per Share

98.498

Quarterly Revenue Growth

(0.43)

The market value of MEDIFAST INC is measured differently than its book value, which is the value of MEDIFAST that is recorded on the company's balance sheet. Investors also form their own opinion of MEDIFAST INC's value that differs from its market value or its book value, called intrinsic value, which is MEDIFAST INC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MEDIFAST INC's market value can be influenced by many factors that don't directly affect MEDIFAST INC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between MEDIFAST INC's value and its price as these two are different measures arrived at by different means. Investors typically determine if MEDIFAST INC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MEDIFAST INC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

MEDIFAST Interest Expense vs Non Operating Income Net Other Analysis

Interest Expense vs Non Operating Income Net Other

Interest Expense vs Non Operating Income Net Other Correlation Analysis

Correlation Coefficient

Interest Expense

Non Operating Income Net Other

MEDIFAST INC fundamental ratios Correlations

MEDIFAST INC Account Relationship Matchups

High Positive Relationship

High Negative Relationship

MEDIFAST INC fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Complementary Tools for MEDIFAST Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Liab	+ 1.0	Total Current Liabilities
Common Stock	+ 1.0	Common Stock Total Equity
Total Current Assets	+ 0.99	Total Assets
Non Current Assets Total	+ 0.99	Property Plant And Equipment Net
Property Plant And Equipment Gross	+ 0.99	Non Current Assets Total
Total Current Liabilities	+ 0.97	Other Current Liab

Cash	- 0.96	Net Debt
Cash And Short Term Investments	- 0.89	Net Debt
Total Current Assets	- 0.73	Net Debt
Retained Earnings	- 0.72	Net Debt
Net Debt	- 0.66	Other Current Liab
Net Debt	- 0.65	Total Stockholder Equity